MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.58

+1.4%

Nov 5 12:44 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (689)	6/20/2003 5:54:01 PM
From: keokalani'nui	Read Replies (1) of 2240

BOTHELL, Wash., June 20 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBT.OB - News) today announced the cash sale of certain future royalty rights to Medarex, Inc. and the implementation of additional measures to conserve capital. Under the terms of its agreement with Medarex, the Company has granted Medarex the right to receive any future royalties from products derived from a certain identified antibody target. In exchange for these future royalties, Medarex will pay the Company $816,000. (snip) __________ __________ Previously, as part of the nwbt denoument, medx acquired nwbt's rights to pmsa and 3 unspecified antigens.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next